AG Combined With Cadonilimab Sequential Short-course Radiotherapy in the Treatment of Locally aPDAC

NCT06472037 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: Cadonilimab
DRUG: Gemcitabine
DRUG: Nab-Paclitaxel

Sponsor

Tianjin Medical University Cancer Institute and Hospital